Bacillus Calmette-Guérin
Bacillus Calmette–Guerin is a vaccine against tuberculosis. It is often abbreviated BCG. The vaccine is based on a bovine strain of the bacterium. It was developed by Albert Calmette and Camille Guerin in the 1930s. It looks like the vaccine can also be used to treat certain forms of bladder cancer.[1]
Bacillus Calmette-Guérin Media
Micrograph showing granulomatous inflammation of bladder neck tissue due to Bacillus Calmette–Guérin used to treat bladder cancer, H&E stain
An apparatus (4–5 cm length, with 9 short needles) used for BCG vaccination in Japan, shown with ampules of BCG and saline
French poster promoting the BCG vaccine
References
- ↑ De Jager R, Guinan P, Lamm D, u. a.: Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology. 1991 Dec;38(6):507-13. PMID 1836081
